Literature DB >> 4047091

Cultured rat spinal cord neurons: interaction with motor neuron disease immunoglobulins.

J Digby, R Harrison, A Jehanli, G G Lunt, F Clifford-Rose.   

Abstract

Conditions have been developed for the culture of rat spinal cord neurons in serum-free media supplemented with hormones and growth factors. Neurons were identified by immunofluorescence-labeled anti-neurofilament antibody, and their growth was monitored by assay of choline acetyltransferase and cholinesterase activities. Activities of these enzymes were considerably higher than those of comparable cultures in serum supplemented media in which there were visibly many more nonneuronal cells. Serum immunoglobulins from patients with motor neuron disease showed enhanced binding to rat spinal cord cells maintained in both serum-supplemented and serum-free media, as compared with those from normal healthy individuals. Enhanced binding was more marked with the latter cells, presumably because of the higher proportion of neuronal cells in these cultures. Serum immunoglobulins from patients with other neurologic disorders showed a similar binding to that of the normal controls. The results demonstrate the presence of an immune response to spinal cord cell membrane components in patients with motor neuron disease, although whether the response is primary or secondary in the disease process remains unclear.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4047091     DOI: 10.1002/mus.880080709

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  2 in total

1.  Serum antibodies to central nervous system antigens: an analysis of their relation with different human neurologic disorders.

Authors:  P Huppi; L Bologa; N Herschkowitz
Journal:  Neurochem Res       Date:  1987-07       Impact factor: 3.996

2.  Intramuscular nerves in motor neurone disease. A quantitative ultrastructural study.

Authors:  C P Case; M Jelaca
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.